PRESS RELEASE

Q4 2021 — Press release

Q4 2021PDF · 8 pages353 KB
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results
CHICAGO, February 9, 2022 - CME Group Inc. (NASDAQ: CME) today reported
financial results for the fourth quarter and full year of 2021.
The company reported revenue of $1.1 billion and operating income of $632 million for
the fourth quarter of 2021. Net income was $625 million and diluted earnings per common
share were $1.71. On an adjusted basis, net income was $608 million and diluted earnings per
common share were $1.66. Financial results presented on an adjusted basis for the fourth
quarter of 2021 and 2020 exclude certain items, which are detailed in the reconciliation of non-
GAAP results. 1
Total revenue for full-year 2021 was $4.7 billion and operating income was $2.6 billion.
Net income was $2.6 billion and diluted earnings per common share were $7.29. On an
adjusted basis, net income was $2.4 billion, and diluted earnings per common share were
$6.67.
"We achieved record trading volume in 2021, driven by client demand for tools to hedge
against continued economic uncertainty across markets," said CME Group Chairman and Chief
Executive Officer Terry Duffy. "We delivered strong performance across core benchmarks, new
products and international business during 2021. Additionally, we announced a 10-year strategic
partnership with Google Cloud to transform global derivatives markets through cloud adoption,
and introduced several innovative, new micro-sized and ESG-focused products and services.
We are pleased 2022 is off to a strong start with our highest January average daily volume on
record of 24.6 million contracts, led by strong equity index and interest rate volumes, including
numerous SOFR futures and options records, and 10% year-over-year growth in overall open
interest. Moving ahead, we will continue to focus on providing the risk management tools our
clients need to navigate ongoing uncertainties around the world."
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
Media contact 	Investor contact
Chris Grams, 312.930.3435 	John Peschier, 312.930.8491
Laurie Bischel, 312.648.8698 	CME-G
news@cmegroup.com
www.cmegroup.mediaroom.com

-- 1 of 8 --

- more -
Page 2
Fourth-quarter 2021 average daily volume (ADV) was 20.5 million contracts, up 26%
versus fourth-quarter 2020. Non-U.S. ADV for full-year 2021 reached a record 5.5 million
contracts, up 4% compared with the same period in 2020.
Clearing and transaction fees revenue for fourth-quarter 2021 totaled $949 million. The
total average rate per contract was $0.650. Market data revenue totaled $142 million for fourth-
quarter 2021.
As of December 31, 2021, the company had approximately $2.9 billion in cash (including
$100 million deposited with Fixed Income Clearing Corporation (FICC) and included in other
current assets) and $3.4 billion of debt. The company declared dividends during 2021 of
$2.5 billion, including the annual variable dividend of $1.2 billion. The company has returned
over $17.5 billion to shareholders in the form of dividends since the implementation of the
variable dividend policy in early 2012.
CME Group will hold a Q&A conference call to discuss fourth-quarter 2021 results
at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on
the Investor Relations section of CME Group’s website at www.cmegroup.com. An
archived recording will be available for up to two months after the call.
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients
to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering
market participants worldwide to efficiently manage risk and capture opportunities. CME Group
exchanges offer the widest range of global benchmark products across all major asset classes based
on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The
company offers futures and options on futures trading through the CME Globex® platform, fixed income
trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of
the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec, and EBS are trademarks of BrokerTec Europe LTD, EBS Group LTD, respectively. Dow Jones,
Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones
Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC,
as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other
trademarks are the property of their respective owners.

-- 2 of 8 --

- more -
Page 3
Statements in this press release that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are
difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied
in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking
statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of
new information, future events or otherwise. Among the factors that might affect our performance are increasing
competition by foreign and domestic entities, including increased competition from new entrants into our markets
and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementation and maintenance of the enhanced functionality required by
our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to continue introducing competitive new products and services on a timely, cost-effective basis, including
through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products
and services, including our ability to provide effective services to the swaps market; our ability to adjust our fixed
costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading
levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our
products and services; changes in regulations, including the impact of any changes in laws or government policies
with respect to our products or services or our industry, such as any changes to regulations and policies that require
increased financial and operational resources from us or our customers; the costs associated with protecting our
intellectual property rights and our ability to operate our business without violating the intellectual property rights
of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in
various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading
venue and the mix of customers (whether the customer receives member or non-member fees or participates in one
of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and
liquidity risk management practices to adequately protect us from the credit risks of clearing members and other
counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched
principal business; the ability of our compliance and risk management programs to effectively monitor and manage
our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security
breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and
exposure to risk through third parties, including risks related to the performance, reliability and security of
technology used by our third-party providers; volatility in commodity, equity and fixed income prices, and price
volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income
instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of
the capital and credit markets and the impact of economic conditions on the trading activity of our current and
potential customers; the impact of the COVID-19 pandemic and response by governments and other third parties;
our ability to accommodate increases in contract volume and order transaction traffic and to implement
enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to
execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs
and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those
associated with our joint venture with IHS Markit and our partnership with Google Cloud; the uncertainty related to
the transition from LIBOR; our ability to continue to generate funds and/or manage our indebtedness to allow us to
continue to invest in our business; industry and customer consolidation; decreases in trading and clearing activity;
the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax

-- 3 of 8 --

treatment of such transactions; our ability to maintain our brand and reputation; and the unfavorable resolution of
material legal proceedings. For a detailed discussion and additional information concerning these and other factors
that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K
for the year ended December 31, 2020, as filed with the Securities and Exchange Commission ("SEC") on February
26, 2021, under the caption "Risk Factors".
# # #

-- 4 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
December 31, 2021 	December 31, 2020
ASSETS
Current Assets:
Cash and cash equivalents 	$ 	2,834.9 	$ 	1,633.2
Marketable securities 	115.0 	100.9
Accounts receivable, net of allowance 	434.5 	461.3
Other current assets (includes $4.8 and $4.7 in restricted cash) 	427.8 	306.7
Performance bonds and guaranty fund contributions 	157,949.6 	86,781.8
Total current assets 	161,761.8 	89,283.9
Property, net of accumulated depreciation and amortization 	505.3 	579.2
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	3,532.0 	4,865.3
Goodwill 	10,528.0 	10,798.8
Other assets (includes $0.5 and $0.6 in restricted cash) 	3,277.9 	1,957.1
Total Assets 	$ 	196,780.3 	$ 	124,659.6
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable 	$ 	48.8 	$ 	69.3
Short-term debt 	749.4 	—
Other current liabilities 	1,650.6 	1,346.8
Performance bonds and guaranty fund contributions 	157,949.6 	86,781.8
Total current liabilities 	160,398.4 	88,197.9
Long-term debt 	2,695.7 	3,443.8
Deferred income tax liabilities, net 	5,390.4 	5,607.0
Other liabilities 	896.5 	1,059.4
Total Liabilities 	169,381.0 	98,308.1
CME Group Shareholders’ Equity 	27,399.3 	26,319.9
Non-controlling interests 	— 	31.6
Total Equity 	27,399.3 	26,351.5
Total Liabilities and Equity 	$ 	196,780.3 	$ 	124,659.6

-- 5 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
December 31,
Year Ended
December 31,
2021 	2020 	2021 	2020
Revenues
Clearing and transaction fees 	$ 	949.3 	$ 	843.0 	$ 	3,765.1 	$ 	3,897.4
Market data and information services 	142.1 	139.8 	576.9 	545.4
Other 	55.9 	115.7 	347.7 	440.8
Total Revenues 	1,147.3 	1,098.5 	4,689.7 	4,883.6
Expenses
Compensation and benefits 	201.7 	215.6 	837.0 	856.5
Technology 	45.8 	53.6 	192.6 	198.5
Professional fees and outside services 	32.3 	50.0 	151.7 	191.3
Amortization of purchased intangibles 	58.6 	79.0 	237.6 	311.2
Depreciation and amortization 	35.9 	41.5 	147.8 	153.2
Licensing and other fee agreements 	60.4 	57.9 	236.9 	244.9
Other 	80.9 	85.9 	240.9 	290.6
Total Expenses 	515.6 	583.5 	2,044.5 	2,246.2
Operating Income 	631.7 	515.0 	2,645.2 	2,637.4
Non-Operating Income (Expense)
Investment income 	67.8 	31.1 	306.9 	182.7
Interest and other borrowing costs 	(41.9) 	(41.7) 	(166.9) 	(166.2)
Equity in net earnings (losses) of unconsolidated
subsidiaries 	67.5 	46.6 	245.8 	190.6
Other non-operating income (expense) 	74.2 	(16.0) 	342.6 	(122.4)
Total Non-Operating Income (Expense) 	167.6 	20.0 	728.4 	84.7
Income before Income Taxes 	799.3 	535.0 	3,373.6 	2,722.1
Income tax provision 	174.1 	110.2 	736.7 	615.7
Net Income 	625.2 	424.8 	2,636.9 	2,106.4
Less: net (income) loss attributable to non-controlling
interests 	— 	(0.8) 	(0.5) 	(1.2)
Net Income Attributable to CME Group 	625.2 	424.0 	2,636.4 	2,105.2
Net Income Attributable to Common Shareholders of
CME Group 	$ 	613.3 	$ 	424.0 	$ 	2,617.1 	$ 	2,105.2
Earnings per Share Attributable to Common
Shareholders of CME Group:
Basic 	$ 	1.71 	$ 	1.18 	$ 	7.30 	$ 	5.88
Diluted 	1.71 	1.18 	7.29 	5.87
Weighted Average Number of Common Shares:
Basic 	358,582 	358,047 	358,340 	357,764
Diluted 	359,019 	358,612 	358,929 	358,524

-- 6 of 8 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
4Q 2020 	1Q 2021 	2Q 2021 	3Q 2021 	4Q 2021
Trading Days 	64 	61 	63 	64 	64
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 	4Q 2020 	1Q 2021 	2Q 2021 	3Q 2021 	4Q 2021
Interest rates 	6,273 	10,349 	8,581 	8,111 	9,805
Equity indexes 	5,148 	6,117 	4,926 	5,100 	5,943
Foreign exchange 	818 	852 	769 	776 	800
Energy 	1,940 	2,363 	1,963 	2,179 	2,252
Agricultural commodities 	1,478 	1,471 	1,631 	1,141 	1,216
Metals 	568 	675 	568 	480 	475
Total 	16,225 	21,827 	18,438 	17,786 	20,490
Venue
CME Globex 	15,469 	20,436 	17,223 	16,652 	19,043
Open outcry 	273 	678 	646 	598 	792
Privately negotiated 	483 	713 	569 	536 	656
Total 	16,225 	21,827 	18,438 	17,786 	20,490
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 	4Q 2020 	1Q 2021 	2Q 2021 	3Q 2021 	4Q 2021
Interest rates 	$ 	0.490 	$ 	0.475 	$ 	0.491 	$ 	0.483 	$ 	0.487
Equity indexes 	0.523 	0.532 	0.555 	0.555 	0.526
Foreign exchange 	0.739 	0.779 	0.805 	0.803 	0.779
Energy 	1.165 	1.097 	1.140 	1.127 	1.111
Agricultural commodities 	1.301 	1.343 	1.343 	1.319 	1.323
Metals 	1.389 	1.415 	1.438 	1.463 	1.452
Average RPC 	$ 	0.699 	$ 	0.658 	$ 	0.695 	$ 	0.677 	$ 	0.650
1. ADV and RPC includes futures and options on futures only.

-- 7 of 8 --

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
December 31,
Year Ended
December 31,
2021 	2020 	2021 	2020
Net Income Attributable to CME Group 	$ 	625.2 	$ 	424.0 	$ 	2,636.4 	$ 	2,105.2
Restructuring and severance 	10.1 	5.5 	35.9 	22.1
Amortization of purchased intangibles(1) 	69.9 	79.0 	253.0 	311.2
Litigation matters 	(15.7) 	0.8 	(18.8) 	8.2
Strategic transaction-related costs(2) 	5.3 	16.2 	41.3 	42.6
Foreign exchange transaction losses 	(0.6) 	6.9 	(0.4) 	9.3
Unrealized and realized (gains) losses on investments 	(62.5) 	0.5 	(518.0) 	6.8
Gain on sale of real estate 	(30.4) 	— 	(30.4) 	—
(Gains) Losses on derivatives 	— 	— 	— 	(1.5)
Realized and unrealized losses on assets(3) 	0.3 	4.3 	2.0 	33.1
Trading floor enhancements 	4.6 	— 	6.0 	2.5
Income tax effect related to above 	6.6 	(24.2) 	(27.5) 	(109.9)
Other income tax items 	(5.3) 	(15.9) 	32.2 	(18.5)
Adjusted Net Income Attributable to CME Group 	$ 	607.5 	$ 	497.1 	$ 	2,411.7 	$ 	2,411.1
Adjusted Net Income Attributable to Common
Shareholders of CME Group 	$ 	595.7 	$ 	497.1 	$ 	2,392.8 	$ 	2,411.1
Earnings per Share Attributable to Common
Shareholders of CME Group:
Basic 	$ 	1.71 	$ 	1.18 	$ 	7.30 	$ 	5.88
Diluted 	1.71 	1.18 	7.29 	5.87
Adjusted Earnings per Share Attributable to
Common Shareholders of CME Group:
Basic 	$ 	1.66 	$ 	1.39 	$ 	6.68 	$ 	6.74
Diluted 	1.66 	1.39 	6.67 	6.72
Weighted Average Number of Shares:
Basic common shares 	358,582 	358,047 	358,340 	357,764
Diluted common shares 	359,019 	358,612 	358,929 	358,524
Preferred shares(4) 	2,890 	— 	728 	—
1. Includes $11.2 million of amortization of purchased intangibles (net of tax) at OSTTRA, reported in Equity in
net earnings of unconsolidated subsidiaries.
2. Strategic transaction-related costs primarily include professional fees related to the NEX integration and Google
transaction.
3. Results include net gains and losses on intangible assets, fixed assets and assets held for sale.
4. Preferred shares have similar rights as common shares without voting rights. A total of 4.6 million shares were
issued and outstanding as of December 31, 2021.
22-16

-- 8 of 8 --